Teachers Advisors LLC grew its stake in Alkermes PLC (NASDAQ:ALKS) by 8.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 169,027 shares of the company’s stock after acquiring an additional 13,716 shares during the quarter. Teachers Advisors LLC owned about 0.11% of Alkermes PLC worth $9,798,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in ALKS. Greenwood Capital Associates LLC raised its position in shares of Alkermes PLC by 1.1% in the 2nd quarter. Greenwood Capital Associates LLC now owns 3,770 shares of the company’s stock worth $219,000 after acquiring an additional 41 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in Alkermes PLC by 0.6% during the first quarter. PNC Financial Services Group Inc. now owns 7,104 shares of the company’s stock valued at $415,000 after purchasing an additional 42 shares in the last quarter. World Asset Management Inc boosted its position in Alkermes PLC by 1.9% during the second quarter. World Asset Management Inc now owns 6,939 shares of the company’s stock valued at $402,000 after purchasing an additional 128 shares in the last quarter. Capstone Asset Management Co. boosted its position in Alkermes PLC by 2.6% during the second quarter. Capstone Asset Management Co. now owns 6,755 shares of the company’s stock valued at $392,000 after purchasing an additional 170 shares in the last quarter. Finally, M&T Bank Corp boosted its position in Alkermes PLC by 4.0% during the first quarter. M&T Bank Corp now owns 6,935 shares of the company’s stock valued at $405,000 after purchasing an additional 266 shares in the last quarter. Institutional investors and hedge funds own 99.07% of the company’s stock.

Several equities analysts have issued reports on ALKS shares. Credit Suisse Group reiterated a “buy” rating and issued a $70.00 target price on shares of Alkermes PLC in a research note on Wednesday, June 7th. Leerink Swann lowered shares of Alkermes PLC from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $68.00 to $61.00 in a research report on Tuesday, June 13th. J P Morgan Chase & Co set a $78.00 price target on shares of Alkermes PLC and gave the company a “buy” rating in a research report on Saturday, July 1st. ValuEngine cut shares of Alkermes PLC from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Finally, BidaskClub cut shares of Alkermes PLC from a “hold” rating to a “sell” rating in a report on Monday, July 31st. One research analyst has rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the stock. Alkermes PLC presently has a consensus rating of “Hold” and a consensus price target of $64.13.

WARNING: “Teachers Advisors LLC Has $9.80 Million Stake in Alkermes PLC (ALKS)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/teachers-advisors-llc-has-9-80-million-stake-in-alkermes-plc-alks/1606835.html.

In related news, Director Paul J. Mitchell sold 1,500 shares of the stock in a transaction on Friday, September 1st. The stock was sold at an average price of $50.77, for a total value of $76,155.00. Following the transaction, the director now owns 9,500 shares of the company’s stock, valued at $482,315. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Kathryn L. Biberstein sold 13,566 shares of the stock in a transaction on Monday, September 11th. The shares were sold at an average price of $51.29, for a total value of $695,800.14. Following the completion of the transaction, the chief accounting officer now directly owns 70,455 shares in the company, valued at approximately $3,613,636.95. The disclosure for this sale can be found here. Insiders sold a total of 16,566 shares of company stock worth $854,320 over the last 90 days. Company insiders own 5.34% of the company’s stock.

Shares of Alkermes PLC (NASDAQ:ALKS) opened at 51.43 on Wednesday. The firm’s market cap is $7.90 billion. The firm has a 50-day moving average price of $50.95 and a 200 day moving average price of $55.96. Alkermes PLC has a one year low of $41.93 and a one year high of $63.40.

Alkermes PLC (NASDAQ:ALKS) last posted its quarterly earnings results on Thursday, July 27th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.02. Alkermes PLC had a negative net margin of 24.33% and a negative return on equity of 9.12%. The company had revenue of $218.80 million during the quarter, compared to analysts’ expectations of $216.54 million. During the same quarter in the previous year, the business posted ($0.01) EPS. The firm’s revenue was up 12.1% on a year-over-year basis. On average, analysts forecast that Alkermes PLC will post ($0.04) earnings per share for the current fiscal year.

Alkermes PLC Company Profile

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS).

Institutional Ownership by Quarter for Alkermes PLC (NASDAQ:ALKS)

Receive News & Ratings for Alkermes PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.